home    about    contact    disclaimer    links    privacy    

service · about.html

The European Society for Hyperthermic Oncology

ESHO financial statement 2016 >>
ESHO financial statement 2015 >>
ESHO financial statement 2014 >>
ESHO financial statement 2013 >>

The object of the European Society for Hyperthermic Oncology (ESHO) is to promote for the public benefit, fundamental and applied research in physics, engineering, biological and clinical sciences relating to the use of hyperthermia in cancer therapy.

Moreover, the society wants to facilitate integration and exchange of information between different disciplines in the study of the biological effects of heat in the treatment of cancer either alone or combined with other cancer treatment modalities.

The European Society for Hyperthermic Oncology was established in 1987 in England. In 1992, the registered office of the Society was transferred to The Netherlands.

Board Members: G.C. van Rhoon (The Netherlands), M.R. Horsman (Denmark), GJ. van Tienhoven (The Netherlands), O.J. Ott (Germany), T.L.M. ten Hagen (The Netherlands), V. Kouloulias (Greece), S. Dall'Oglio (Italy), L.H. Lindner (Germany), M. Persson (Sweden).

ESHO statutes and membership >>
ESHO Strategy Plan 2014-19 PDF >>